NCT05791851View on ClinicalTrials.gov

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

June 14, 2022

Study Completion Date

June 14, 2022

Conditions
HIV InfectionsHepatitis BVaccine Response Impaired
Trial Locations (2)

21201

Baltimore Veterans Affairs Medical Center, Baltimore

Institute of Human Virology, Baltimore

All Listed Sponsors
collaborator

Baltimore VA Medical Center

FED

lead

University of Maryland, Baltimore

OTHER

NCT05791851 - Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders | Biotech Hunter | Biotech Hunter